Background: Previous studies validated the prognostic significance of lymphocyte to monocyte ratio (LMR) in patients with solid tumors and some hematologic malignancies. However, the correlation between LMR and Myelodysplastic Neoplasms (MDS) was unclear. The study intends to investigate the prognostic impact of LMR on MDS patients. Methods: 91 newly diagnosed MDS patients were included in this retrospective study. The cut-off of LMR was 3.2 by X-Tile. All patients were divided into the low LMR group (<3.2) and the high LMR group (>= 3.2). Clinical characteristics were compared between the two groups. Results: Patients in the high LMR group (n = 67) had better OS (P = 0.007) from the Kaplan-Meier survival curves. The results of the univariate analysis demonstrated that LMR was a prognostic factor for OS [hazard ratio (HR) = 2.070, 95%CI 1.201-3.571, P = 0.009]. After multivariate cox analysis, low LMR was confirmed to be an independent predictor of poor OS in MDS patients (HR = 1.872, 95%CI 1.084-3.230, P = 0.024). Conclusions: LMR, a representative marker of systematic inflammation and immune response, has potential prognostic significance in MDS patients.
[1]Nanjing Med Univ, Dept Hematol, Affiliated Huaian 1 Peoples Hosp, Huaian, Peoples R China.
[2]Nanjing Med Univ, Key Lab Hematol, Nanjing, Peoples R China.
(8.0+极速模式)